Biorce

About Biorce

Our mission is to dramatically reduce the time and cost of clinical trials. Aika, our AI platform, supports the various stages of the clinical trial lifecycle Phase 1-3, up until market approval. Clinical trials can take 11 years and cost ∼$6.2B to bring a drug to market. 57% face costly protocol amendments that add months of delay. We're changing that. With Aika, users can generate compliant and comprehensive documents (feasibility studies, entire protocols, application forms, financial documents, consent forms etc.) within minutes. Aika features nearly 100% of clinical trials published in the past 25 years (1M+ trials from official registries), 260K+ clinical trial protocols, peer-reviewed articles, regulatory guidelines and many more. Every recommendation is backed by verifiable sources. Every decision stays with the clinical experts. Human oversight guaranteed. Faster trials don’t mean more risk. With Aika, they mean smarter science. The impact: → 50% faster protocol development → $200K-$400K saved per avoided amendment → Regulatory-ready outputs from day one Built by clinical experts, for clinical experts.